These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1424 related items for PubMed ID: 23155689
1. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone? Colmenares A, González L, Gunczler P, Lanes R. J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689 [Abstract] [Full Text] [Related]
2. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Högler W, Briody J, Moore B, Lu PW, Cowell CT. Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578 [Abstract] [Full Text] [Related]
3. Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment. Soliman A, Rogol AD, Elsiddig S, Khalil A, Alaaraj N, Alyafie F, Ahmed H, Elawwa A. J Pediatr Endocrinol Metab; 2021 Oct 26; 34(10):1263-1271. PubMed ID: 34291621 [Abstract] [Full Text] [Related]
4. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature. Kriström B, Aronson AS, Dahlgren J, Gustafsson J, Halldin M, Ivarsson SA, Nilsson NO, Svensson J, Tuvemo T, Albertsson-Wikland K. J Clin Endocrinol Metab; 2009 Feb 26; 94(2):483-90. PubMed ID: 19001519 [Abstract] [Full Text] [Related]
5. Growth hormone regimens in Australia: analysis of the first 3 years of treatment for idiopathic growth hormone deficiency and idiopathic short stature. Hughes IP, Harris M, Choong CS, Ambler G, Cutfield W, Hofman P, Cowell CT, Werther G, Cotterill A, Davies PS, Australasian Paediatric Endocrine Group (APEG). Clin Endocrinol (Oxf); 2012 Jul 26; 77(1):62-71. PubMed ID: 21950731 [Abstract] [Full Text] [Related]
6. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study. Soliman AT, Elawwa A, Itani M, Jour C, De Sanctis V. Acta Biomed; 2019 Sep 23; 90(8-S):43-51. PubMed ID: 31544806 [Abstract] [Full Text] [Related]
7. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency. Zucchini S, Pirazzoli P, Baronio F, Gennari M, Bal MO, Balsamo A, Gualandi S, Cicognani A. J Clin Endocrinol Metab; 2006 Nov 23; 91(11):4271-6. PubMed ID: 16912138 [Abstract] [Full Text] [Related]
8. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience. Kohn B, Julius JR, Blethen SL. Pediatrics; 1999 Oct 23; 104(4 Pt 2):1014-8. PubMed ID: 10506254 [Abstract] [Full Text] [Related]
9. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency. Lagrou K, Xhrouet-Heinrichs D, Massa G, Vandeweghe M, Bourguignon JP, De Schepper J, de Zegher F, Ernould C, Heinrichs C, Malvaux P, Craen M. J Pediatr Endocrinol Metab; 2001 Oct 23; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020 [Abstract] [Full Text] [Related]
10. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone. Pasquino AM, Pucarelli I, Roggini M, Segni M. J Clin Endocrinol Metab; 2000 Feb 23; 85(2):619-22. PubMed ID: 10690865 [Abstract] [Full Text] [Related]
11. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand. Wacharasindhu S, Supornsilchai V, Aroonparkmongkol S, Srivuthana S. J Med Assoc Thai; 2007 Oct 23; 90(10):2047-52. PubMed ID: 18041422 [Abstract] [Full Text] [Related]
12. Final height in children with idiopathic growth hormone deficiency treated with a fixed dose of recombinant growth hormone. Rachmiel M, Rota V, Atenafu E, Daneman D, Hamilton J. Horm Res; 2007 Oct 23; 68(5):236-43. PubMed ID: 17396034 [Abstract] [Full Text] [Related]
13. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children. Cohen P, Germak J, Rogol AD, Weng W, Kappelgaard AM, Rosenfeld RG, American Norditropin Study Group. J Clin Endocrinol Metab; 2010 May 23; 95(5):2089-98. PubMed ID: 20207829 [Abstract] [Full Text] [Related]
14. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database). Darendeliler F, Ranke MB, Bakker B, Lindberg A, Cowell CT, Albertsson-Wikland K, Reiter EO, Price DA. Horm Res; 2005 May 23; 63(1):40-7. PubMed ID: 15627781 [Abstract] [Full Text] [Related]
15. Effect of growth hormone treatment on craniofacial growth in children: Idiopathic short stature versus growth hormone deficiency. Choi SH, Fan D, Hwang MS, Lee HK, Hwang CJ. J Formos Med Assoc; 2017 Apr 23; 116(4):313-321. PubMed ID: 27421175 [Abstract] [Full Text] [Related]
16. Height Gain and Safety Outcomes in Growth Hormone-Treated Children with Idiopathic Short Stature: Experience from a Prospective Observational Study. Child CJ, Quigley CA, Cutler GB, Moore WV, Wintergerst KA, Ross JL, Rosenfeld RG, Blum WF. Horm Res Paediatr; 2019 Apr 23; 91(4):241-251. PubMed ID: 31185471 [Abstract] [Full Text] [Related]
17. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height. Toumba M, Bacopoulou I, Savva SC, Skordis N. Indian Pediatr; 2007 Jul 23; 44(7):497-502. PubMed ID: 17684302 [Abstract] [Full Text] [Related]
18. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. Kamp GA, Mul D, Waelkens JJ, Jansen M, Delemarre-van de Waal HA, Verhoeven-Wind L, Frölich M, Oostdijk W, Wit JM. J Clin Endocrinol Metab; 2001 Jul 23; 86(7):2969-75. PubMed ID: 11443153 [Abstract] [Full Text] [Related]
19. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency. Giovenale D, Meazza C, Cardinale GM, Farinelli E, Mastrangelo C, Messini B, Citro G, Del Vecchio M, Di Maio S, Possenti I, Bozzola M. J Pediatr Gastroenterol Nutr; 2007 Oct 23; 45(4):433-7. PubMed ID: 18030209 [Abstract] [Full Text] [Related]
20. Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: the National Cooperative Growth Study experience. August GP, Julius JR, Blethen SL. Pediatrics; 1998 Aug 23; 102(2 Pt 3):512-6. PubMed ID: 9685455 [Abstract] [Full Text] [Related] Page: [Next] [New Search]